Identification of Differentially Expressed Genes Associated with Prognosis of B Acute Lymphoblastic Leukemia

Table 2

Differences in gene expression levels through time in 73 B-ALL patients.

Gene	Times included in the comparison and significant; values
	Time 1/time 2	Time 1/time 3	Time 2/time 3
IL2RA	0.011	ns	ns
IL10	0.012	ns	ns
CD10	0.016	ns	ns
CD3D	0.018	ns	ns
HOXA9	0.041	ns	ns
PAX5	0.006	ns	ns
CTNNB	ns	0.039	ns
GSK3B	ns	0.003	ns
JAK2	ns	0.032	ns
FOS1	ns	0.007	ns
RAPGEF2	ns	0.044	ns
SORT1	ns	0.023	ns
HK2	ns	0.007	ns
PAX5	ns	0.002	ns
DEFA1	ns	0.011	ns
NOTCH1	ns	0.026	ns
S100A8	ns	0.002	ns
	ns	ns	0.037
BCL11A	0.023	ns	ns
	ns	0.012	ns
STAT5	0.017	ns	ns
	ns	0.012	ns
OPAL1	0.04	ns	ns
	ns	0.018	ns
FLT3	<0.001	ns	ns
	ns	0.009	ns
RXRA	0.01	ns	ns
	ns	0.002	ns
BCL2A	0.005	ns	ns
	ns	<0.001	ns
	ns	ns	0.005

ns: nonsignificant, value >0.05.